Medpace Holdings, Inc. (MEDP)

Medpace Holdings Revenue

Medpace Holdings had revenue of $716.00M in the quarter ending September 30, 2026, with 8.50% growth. This brings the company's total for the last twelve months to $2.84B, up 20.35% year-over-year. In the year 2025, Medpace Holdings had annual revenue of $2.53B with 19.97% growth. That makes Medpace Holdings the 3,958th largest company in the world by revenue and 1,087th in the United States.

• Revenue (ttm): $2.84B
• Revenue Growth: +20.35%
• P/S Ratio: 6.67
• Revenue / Employee: $436,675
• Employees: 6,500
• Market Cap: 18.91B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Oncology 747.59M 29.5%
• Metabolic 744.96M 29.4%
• Other Sources 408.55M 16.1%
• Central Nervous System 254.84M 10.1%
• Cardiology 239.37M 9.5%
• AVAI 134.94M 5.3%

By Geography

• United States 2.50B 99.0%
• Foreign 25.30M 1.0%

Fiscal year ended Dec 31, 2025 See the full Medpace Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.53B	421.18M	19.97%
Dec 31, 2024	2.11B	223.21M	11.84%
Dec 31, 2023	1.89B	425.85M	29.17%
Dec 31, 2022	1.46B	317.62M	27.80%
Dec 31, 2021	1.14B	216.45M	23.38%
Dec 31, 2020	925.93M	64.96M	7.54%
Dec 31, 2019	860.97M	156.38M	22.19%
Dec 31, 2018	704.59M	268.44M	61.55%
Dec 31, 2017	436.15M	14.57M	3.46%
Dec 31, 2016	421.58M	62.52M	17.41%
Dec 31, 2015	359.06M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error